Multiphase redistribution differences of polycyclic aromatic hydrocarbons (PAHs) between two successive sediment suspensions

Successive sediment suspensions often happen in estuary, yet little research has probed into the difference in the release behaviors of organic compounds among different suspensions. This study took polycyclic aromatic hydrocarbons (PAHs) as typical organic contaminants and investigated the release behaviors between two successive suspensions with a particle entrainment simulator (PES). Results showed that successive sediment suspensions lowered the concentration of dissolved PAHs in the overlying water via facilitating the re-adsorption of dissolved PAHs onto the suspended particles. Fast-release and slow-release periods of PAHs were successively observed in the both suspensions. The concentration changes of dissolved PAHs in the second suspension were generally similar with but hysteretic to those in the first suspension. More vigorous desorption and re-absorption of PAHs were induced in the second suspension. Successive sediment suspensions obviously decreased the concentrations of mineral composition and organic matters in the overlying water, which significantly affects multiphase distribution of PAHs.     

机体细胞镉摄入离子转运通道研究进展

镉是人体非必需金属离子,长期镉暴露易引发镉中毒。机体内没有负责镉转运的特定载体,镉可通过必需金属离子转运载体进入机体细胞。机体内能够转运镉的载体有多种,主要包括铁的转运载体二价金属离子转运蛋白1(DMT1)、钙离子通道(电压门控钙通道(VGCC)、瞬时感受器电位(TRP)和钙库调控的钙通道(SOC))以及锌铁调控蛋白ZIP家族中的ZIP8和ZIP14等,且不同的机体细胞镉吸收所需转运载体不同。转运载体对镉离子的转运符合米氏方程,不同载体调节镉吸收的米氏常数Km值不同。机体细胞镉的吸收是个复杂的过程,通常存在着多种转运载体的交互作用,机体细胞可根据环境变化而选择镉的转运载体。对镉的生理毒性,以及细胞镉吸收常用的转运载体类型加以阐述,并分析了不同机体细胞镉吸收的可能转运载体,以期为后续探究机体细胞镉吸收具体分子机制提供理论指导。     

Dystrophin protein and rflp analyis for fetal diagnosis and carrier confirmation of duchenne muscular dystrophy

A pregnant woman with indeterminate Duchenne muscular dystrophy (DMD) carrier status, but with DMD diagnosed in her deceased brother (unavailable for study), presented for prenatal diagnosis, intending to continue the pregnancy only if proven unaffected with DMD with near absolute certainty. Creatine kinase (CK) assays to clarify carrier status were inconclusive. Male sex in the fetus was identified, but DNA restriction fragment length polymorphism (RFLP) analysis was not yet available to this centre to investigate the possible transmission of the DMD gene, and the pregnancy was terminated. Tissue histology and dystrophin protein analysis demonstrated the absence of DMD. In a situation with proven maternal carrier status, future fetal inheritance of the opposite maternal X chromosome would indicate the presence of DMD. However, maternal carrier status remained in doubt through a second pregnancy, even with RFLP studies, and was finally established when dystrophin analysis confirmed the presence of DMD in the second fetus. Histologic findings are presented, contrasting features in the two fetuses. The value of dystrophin analysis for establishing the diagnosis of fetal DMD, in this case proving maternal carrier status in a difficult situation, and for demonstrating DMD gene:RFLP haplotype relationships is illustrated.     

Leaching,mobility and persistence of tebufenozide in columns packed with forest litter and soil

Abstract

Leaching, downward mobility and persistence of tebufenozide was investigated under laboratory conditions in columns packed with forest litter and soil, after fortification with the analytical grade material (purity > 99.6%) and with two commercial formulations, RH‐5992 2F (aqueous flowable) and RH‐5992 ES (emulsion suspension). Two types of litter and soil were used: one type with relatively high amounts of sand and the other with high amounts of clay.

The concentrations eluted in the leachates were lower when the analytical material (dissolved in acetone) was used for fortification, than when the two formulations (diluted with water) were used. The amount leached was higher for RH‐5992 2F than for RH‐5992 ES. The type of substrate, i.e., sandy or clay type, had only marginal influence on the amounts eluted in the leachates. Downward movement of tebufenozide from the top 2‐cm layer to the untreated middle and bottom layers (3‐cm segments) was consistently lower when the analytical material was used for fortification, than when the two formulations were used. Downward movement was higher for RH‐5992 2F than for RH‐5992 ES. Persistence of tebufenozide in substrates, maintained under submerged conditions for 70 days after leaching, indicated an initial 2‐week lag period prior to the onset of degradation. Formulation‐related differences were observed in the half‐life (DT₅₀) values. When the analytical material was used for fortification, the DT₅₀ ranged from ca 54 to 59 d. However, when the formulations were used for fortification, the DT₅₀ showed a higher range, i.e., from ca 62 to 67 d for RH‐5992 2F and ca 70 to 80 d for RH‐5992 ES. Formulation ingredients appear to have caused enhanced adsorption of tebufenozide onto the substrates, thus delaying degradation.     

石化废水深度处理用臭氧催化氧化体系的研究＊

文章就臭氧催化氧化体系在石化废水处理中的作用进行了深入研究,对催化剂载体、催化剂配伍体系以及臭氧的投加方式进行了优化筛选。根据实验,多元催化掺杂体系较一元催化体系氧化效果好,CODCr的去除率可由一元催化时的20%提高到多元催化时的33%;在臭氧的投加方式上,分段投加要优于单级投加,臭氧投加分配比例为6∶3∶1时,CODCr的去除率可由单一投加时的9%提高到分级投加时的19%。     

汽车NVH测试评价方法

本文针对汽车NVH测试评价,分别从汽车NVH关注点、评价要求和条件做了介绍,并就汽车车内噪声、动力总成悬置隔振和支架共振频率、悬挂隔振特性等方面进行了较详细的实例评价.     

金属系无机抗菌材料研究进展

主要介绍金属系无机抗菌材料。从材料的选择和合成方面,讨论了材料的特性和抗菌功能相结合的途径,归纳出抗菌材料的制备工艺的一般规律,为开发适合我国国情的无机抗菌材料提供思路。     

污水处理移动床生物膜反应器悬浮载体研究进展

介绍了移动床生物膜反应器(MBBR)中悬浮载体的种类和特性,讨论了对其性能的影响因素,总结了当前悬浮载体改性技术及性能评价的方法,并对后续研究提出了建议。     

多孔柔性载体在非流化状态下处理污水的效能

对自行研制的多孔柔性载体在非流化状态下,处理低浓度有机污水的效能及生物活性进行了试验,结果表明：污水经处理后,检测指标ＣＯＤＣｒ去除率８０％以上,ＢＯＤ５去除率９０％以上;多孔柔性载体表面附着生物活性较高,可作为良好的生物载体。     

新型聚乙烯填料生物滴滤床净化硫化氢气体的启动研究

研究了新型高密度聚乙烯改良型拉西环填料生物滴滤床净化硫化氢气体的启动过程,重点比较了启动过程中不同的挂膜方式对启动时间及效能的影响.结果表明,采用液相连续流强化挂膜法成膜时间短,在环境温度20～28℃时7 d可以挂膜成功.在启动过程中,随着工艺参数的突然改变(GRT缩短)和入口浓度波动,液相连续流强化挂膜后反应器的硫化氢去除率更稳定.在进气浓度最高为343 mg/m³时硫化氢去除率稳定在95%以上.试验过程中还发现,将SO₄^2-浓度作为活性污泥驯化完成的监测指标、液相S^2-去除率作为挂膜完成的监测指标更合理.启动结束后,通过2种途径减去喷淋液中的碳源并未影响硫化氢的去除率,这进一步表明生物滴滤床中硫化氢的净化主要由自养菌完成.